Sector

Longevity

HealthSpan & LifeSpan

Investment Year

2023

Date

06-May-2023

For more Visit Website

 
We are thrilled to partner with Gottfried and Omiros of Brookstreet. This investment will enable us to take our patient care and experience to the next level, expand our services and facilities, and achieve our goal of becoming one of Europe’s top life-extension centers, helping people live longer and better
— George Xydas, CEO, Swissmed Health

About

Swiss Biological Medicine Center is known for its personalized approach to healthcare, offering a range of medical services including longevity, cancer, autoimmune diseases and more. The center’s team of highly trained and experienced doctors work together to address the root cause of patients' health concerns, creating customised treatment plans tailored to each patient's unique needs.

Brookstreet Completes Investment in Swissmed Health

Swissmed Health, an innovative organization in personalized Swiss medicine, announced today that it has secured a multi-million “Growth Round” from international investors including directly from Members of Brookstreet Equity Partners LLP (“Brookstreet”). The funding will be used to expand the clinic's facilities and accelerate national roll out and international development.

Gottfried Springer and Omiros Sarikas, Members of Brookstreet, stated:

"We have both been interested in Longevity for many years now and connected the dots worldwide. We are delighted to support a platform where we can offer both life-span and health-span protocols. Healthcare 3.0 under the sun, with access to talent both from the European Continent and British Commonwealth as well as ties to CESA, MENA and Asia.”

Next
Next

Perceptual Robotics